FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304943956> ?p ?o ?g. }

• W4304943956 endingPage "1948" @default.
• W4304943956 startingPage "1944" @default.
• W4304943956 abstract "The co-administration of abemaciclib and astragaloside IV might occur in the treatment of breast cancer.This study evaluates the interaction between abemaciclib and astragaloside IV in rats and describes the potential mechanism.Male Sprague Dawley rats were randomly divided into four groups: single dose of abemaciclib (control), abemaciclib + 50 mg/kg/d astragaloside IV, abemaciclib + 100 mg/kg/d astragaloside IV, and abemaciclib + 150 mg/kg/d astragaloside IV. Abemaciclib and astragaloside IV were orally administrated, and astragaloside IV was pre-administrated for 7 d in the co-administrated groups. The pharmacokinetics and transport of abemaciclib were assessed in the absence or presence of astragaloside IV. In mechanism, the activity of CYP3A4 was estimated in human liver microsomes in the presence of astragaloside IV.Astragaloside IV significantly increased the Cmax (from 991.5 ± 116.99 up to 2308.5 ± 55.29 μg/L) and AUC (from 24.49 ± 2.86 up to 66.14 ± 1.17 μg/mL × h) and prolonged the t1/2 (from 19.85 ± 4.65 up to 66.17 ± 28.73 h) of abemaciclib, and the effect was enhanced with the increasing astragaloside IV concentration. Astragaloside IV also suppressed the transport of abemaciclib with the efflux ratio decreasing to 1.35. Astragaloside IV suppressed the activity of CYP3A4 with an IC50 value of 21.78 μM.The co-administration of abemaciclib and astragaloside IV induced the increasing systemic exposure of abemaciclib through the inhibition of CYP3A4. Further clinical validations could be carried out according to the study design of the present investigation." @default.
• W4304943956 created "2022-10-13" @default.
• W4304943956 creator A5000884730 @default.
• W4304943956 creator A5049264813 @default.
• W4304943956 creator A5085360089 @default.
• W4304943956 creator A5088419681 @default.
• W4304943956 date "2022-10-13" @default.
• W4304943956 modified "2023-10-17" @default.
• W4304943956 title "Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats" @default.
• W4304943956 cites W1974045981 @default.
• W4304943956 cites W2149711855 @default.
• W4304943956 cites W2320793612 @default.
• W4304943956 cites W2362935464 @default.
• W4304943956 cites W2402797587 @default.
• W4304943956 cites W2559963104 @default.
• W4304943956 cites W2617437931 @default.
• W4304943956 cites W2620993107 @default.
• W4304943956 cites W2763875663 @default.
• W4304943956 cites W2792040629 @default.
• W4304943956 cites W2799401639 @default.
• W4304943956 cites W2803361740 @default.
• W4304943956 cites W2889099029 @default.
• W4304943956 cites W2889143864 @default.
• W4304943956 cites W2984599876 @default.
• W4304943956 cites W3005929774 @default.
• W4304943956 cites W3008103065 @default.
• W4304943956 cites W3010879084 @default.
• W4304943956 cites W3014724320 @default.
• W4304943956 cites W3093890162 @default.
• W4304943956 cites W3101192684 @default.
• W4304943956 cites W3112042435 @default.
• W4304943956 cites W3116228263 @default.
• W4304943956 cites W3168578069 @default.
• W4304943956 cites W3177398181 @default.
• W4304943956 cites W3210887366 @default.
• W4304943956 cites W4205625845 @default.
• W4304943956 cites W4206349107 @default.
• W4304943956 cites W4210689174 @default.
• W4304943956 cites W4226170217 @default.
• W4304943956 doi "https://doi.org/10.1080/13880209.2022.2125539" @default.
• W4304943956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36226863" @default.
• W4304943956 hasPublicationYear "2022" @default.
• W4304943956 type Work @default.
• W4304943956 citedByCount "2" @default.
• W4304943956 countsByYear W43049439562023 @default.
• W4304943956 crossrefType "journal-article" @default.
• W4304943956 hasAuthorship W4304943956A5000884730 @default.
• W4304943956 hasAuthorship W4304943956A5049264813 @default.
• W4304943956 hasAuthorship W4304943956A5085360089 @default.
• W4304943956 hasAuthorship W4304943956A5088419681 @default.
• W4304943956 hasBestOaLocation W43049439561 @default.
• W4304943956 hasConcept C112705442 @default.
• W4304943956 hasConcept C126322002 @default.
• W4304943956 hasConcept C179998833 @default.
• W4304943956 hasConcept C185592680 @default.
• W4304943956 hasConcept C22979827 @default.
• W4304943956 hasConcept C2777061170 @default.
• W4304943956 hasConcept C43617362 @default.
• W4304943956 hasConcept C71924100 @default.
• W4304943956 hasConcept C98274493 @default.
• W4304943956 hasConceptScore W4304943956C112705442 @default.
• W4304943956 hasConceptScore W4304943956C126322002 @default.
• W4304943956 hasConceptScore W4304943956C179998833 @default.
• W4304943956 hasConceptScore W4304943956C185592680 @default.
• W4304943956 hasConceptScore W4304943956C22979827 @default.
• W4304943956 hasConceptScore W4304943956C2777061170 @default.
• W4304943956 hasConceptScore W4304943956C43617362 @default.
• W4304943956 hasConceptScore W4304943956C71924100 @default.
• W4304943956 hasConceptScore W4304943956C98274493 @default.
• W4304943956 hasIssue "1" @default.
• W4304943956 hasLocation W43049439561 @default.
• W4304943956 hasLocation W43049439562 @default.
• W4304943956 hasLocation W43049439563 @default.
• W4304943956 hasOpenAccess W4304943956 @default.
• W4304943956 hasPrimaryLocation W43049439561 @default.
• W4304943956 hasRelatedWork W1532498158 @default.
• W4304943956 hasRelatedWork W1969574919 @default.
• W4304943956 hasRelatedWork W2370929226 @default.
• W4304943956 hasRelatedWork W2379280247 @default.
• W4304943956 hasRelatedWork W2766550598 @default.
• W4304943956 hasRelatedWork W2803361740 @default.
• W4304943956 hasRelatedWork W2942467058 @default.
• W4304943956 hasRelatedWork W2945264506 @default.
• W4304943956 hasRelatedWork W3018168093 @default.
• W4304943956 hasRelatedWork W3122926187 @default.
• W4304943956 hasVolume "60" @default.
• W4304943956 isParatext "false" @default.
• W4304943956 isRetracted "false" @default.
• W4304943956 workType "article" @default.